Expert Interview
Digging in to the Phase 3a STEP TEEN study of once-weekly semaglutide in adolescents with obesity and the potential of Wegovy (semaglutide) in kids ages 12 through 17.
Ticker(s): NVOInstitution: PAGNY
- Pediatric Endocrinologist
- manages 4000 adolescents over the age of 12 with obesity and has prescribed ozempic and trulicity for some of these patients.
- familiar with the results from the Phase 3a STEP TEEN study of once-weekly semaglutide in adolescents with obesity
Do you want answers to these questions?
Slingshot Insights Explained
Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.
Reason
*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.
